Human Fibroblast Extra Cellular Matrix Powder
A cosmetic ingredient used as humectant, skin conditioning, skin conditioning - emollient in skincare, haircare, and personal-care products sold in the European Union.
What is it?
Human Fibroblast Extra Cellular Matrix Powder is the dried, ground powder derived from the extracellular matrix isolated from human fibroblasts.
What does it do?
Human Fibroblast Extra Cellular Matrix Powder is listed in the EU cosmetic ingredient inventory with the following declared functions:
-
Humectant
draws moisture from the air or deeper skin layers to the surface, helping skin retain water
-
Skin conditioning
improves the appearance, feel, and condition of skin
-
Skin conditioning - emollient
softens the skin by reducing roughness and friction between skin cells
EU regulatory status
This ingredient is banned in the European Union.
Human Fibroblast Extra Cellular Matrix Powder is listed under Annex II of EU Cosmetics Regulation 1223/2009 (entry 416), making it prohibited in cosmetic products placed on the EU market.
Frequently asked questions
What is Human Fibroblast Extra Cellular Matrix Powder?
Human Fibroblast Extra Cellular Matrix Powder is a cosmetic ingredient catalogued in the EU CosIng database. Human Fibroblast Extra Cellular Matrix Powder is the dried, ground powder derived from the extracellular matrix isolated from human fibroblasts.
Is Human Fibroblast Extra Cellular Matrix Powder allowed in cosmetics in the EU?
No. Human Fibroblast Extra Cellular Matrix Powder is banned for use in cosmetic products in the EU under Annex II of Regulation 1223/2009.
What does Human Fibroblast Extra Cellular Matrix Powder do in cosmetic products?
Human Fibroblast Extra Cellular Matrix Powder is declared in the EU cosmetic ingredient inventory with these functions: humectant, skin conditioning, skin conditioning - emollient.
Related ingredients
Source: EU CosIng database (European Commission). This page is derived from public-sector information published by the European Commission. · Last updated: 05/04/2019